-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
January 01, 2006 - Most of the CV events with celecoxib
were reported in two large polyp-prevention
trials evaluating 200 … dosage and duration of treatment on
the benefits and harms of oral medication use
• We found no studies evaluating … Given the large number of patients who meet
criteria for aspirin prophylaxis for CV events,
more trials evaluating … Studies evaluating the benefits and risks
associated with such strategies compared with
conventional
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-apbi-breast-cancer.pdf
April 01, 2017 - Three randomized trials evaluating APBI versus WBI
have been published or updated since the original … Data from other large randomized phase 3 trials
evaluating APBI, including the National Surgical Adjuvant … institution similarly showed a 2.6% 5-year risk of
IBTR.16 In addition, a single-institution study evaluating … Prospective multicenter trial
evaluating balloon-catheter partial-breast irradiation for ductal
carcinoma
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-results-search-strategies-developed-with-without-text-mining-tools.pdf
March 01, 2021 - Identification of Irrelevant Records During Search Strategy Evaluation Step ..................... 17
Evaluating … model keyword (title and abstract) terms/phrases, (2) developing model subject heading terms,
and (3) evaluating … Evaluating Seed Set for Bias
As described in the methods section, we developed two questions to evaluate … sets for systematic review searches is presently
unknown, nor have methods been developed to aid in evaluating … Qualitative Results
Identification of Irrelevant Records During Search Strategy Evaluation Step
Evaluating
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-treatments-revised-protocol.pdf
March 29, 2023 - Important subgroups to consider in evaluating this evidence are:
• Specific types of pain: neuropathic … We will evaluate the persistence of
benefits or harms by evaluating the three periods identified in … assigned an overall grade of high, moderate, low, or insufficient
according to a four-level scale by evaluating
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
January 01, 2012 - • Modeling studies evaluating efficacy and harms of
different CKD screening strategies versus usual … • Conduct modeling studies evaluating the effectiveness
and harms of different CKD screening strategies … • Modeling studies evaluating the efficacy and harms of
different CKD monitoring strategies compared … • Conduct modeling studies evaluating the effectiveness
and harms of different CKD monitoring strategies
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
August 01, 2016 - adults, the adequate intake values
for ALA are 1.1 g/d for females and 1.6 g/d for males.5
After evaluating … The
six RCTs evaluating CHF had a similar pattern. … AFib,
and CHF, each based primarily on observational studies;
there was only a single or no RCTs evaluating … o Within 16 studies evaluating diabetes
subgroups, 2 found statistically significant
beneficial effects … There were no observational studies evaluating these
intermediate CVD outcomes.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_disposition-comments.pdf
August 23, 2012 - We thank the reviewer for evaluating the relevance of the
outcomes we have compiled. … guidelines for serum free light
chain analysis in multiple myeloma and related disorders.”1
After evaluating
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/accomplishments-lhs-panel.pdf
November 01, 2021 - Accomplishments of the Learning Health System Panel To Inform and Encourage Use of Evidence Reports
Accomplishments of the Learning Health System Panel
To Inform and Encourage Use of Evidence Reports
October 2018–November 2021October 2018–November 2021
Six LHSs participated in the implementation and evaluation of t…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/machine-learning-tools-appendix-d.xlsx
January 01, 2024 - Data extraction tools
PMID Authors Title PubYear Tool_name Environment Access Model_name Model_type Training ESP_Task Specific_ESP_task Prompts_reported Inputs Outputs Notes Reference_standard Validation N_runs Reports_tested Outcome_description Summary_measure Kappa Kappa_dispersion Correctness Correctness_low Correc…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_executive.pdf
February 01, 2012 - 1
Comparative Effectiveness Review
Number 47
Noninvasive Diagnostic Tests for Breast
Abnormalities: Update of a 2006 Review
Executive Summary
Background
Breast cancer is one of the most
common malignancies of women, with
approximately 200,000 new cases
diagnosed every year in the United
States.1 Some …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-executive-sum.pdf
January 01, 2024 - Recommendations for future research include studies evaluating appropriately
representative and diverse … populations (including adolescents), studies evaluating specific
cannabis-based products available
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_disposition-comments.pdf
April 25, 2013 - More recent
echocardiographic-based methods have focused on
evaluating RV systolic function.” … Peer Reviewer 1 Methods Key Question 2, evaluating management and outcomes in PAH,
includes hemodynamic … This is an important issue in
evaluating to whom the results reported may be applied. … There were few studies evaluating
combination therapy, and the data supporting this had a low
strength … This is a recent
publication evaluating NT-proBNP in a screening algorithm for
PAH in SSc patients.
-
effectivehealthcare.ahrq.gov/products/tinnitus/research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine_protocol-appendix_20111103.pdf
November 03, 2011 - Prophylactic Depakote ER in the Treatment of
Adolescents With Migraine
NCT00297336 An Observational Study Evaluating
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_executive.pdf
April 01, 2013 - For example, a
study evaluating a weight-loss intervention that specified
weight as the primary outcome—but … In contrast, Tosh et al.32 found
a small number of RCTs evaluating general physical
health advice for … Quasi-experimental or clinical records-based
observational studies
Interventions No interventions evaluating … and multisite RCTs
Quasi-experimental or clinical records-based
observational studies
Few studies evaluating … We suggest that observational
designs may be particularly appropriate for these
applications: (1) evaluating
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_disposition-comments.pdf
July 26, 2012 - The authors
chose clinical outcomes as the most important when evaluating
efficacy of treatments. … There is no clearly agreed upon end
point for evaluating the efficacy of stone prevention; however … The authors
chose clinical outcomes as the most important when evaluating
efficacy of treatments. … There is no clearly agreed upon end
point for evaluating the efficacy of stone prevention; however … With that restraint constraint, we’ve
recommended modeling studies evaluating the
effectiveness and
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-239-acute-migraine-evidence-summary.pdf
December 01, 2020 - Evidence Summary for CER 239: Acute Treatments for Episodic Migraine
Comparative Effectiveness Review
Number 239
Acute Treatments for Episodic Migraine
Evidence Summary
Main Points
• Compared with placebo, treatments such as triptans, NSAIDs (nonsteroidal anti-
inflammatory drugs), dihydroergotamine, antieme…
-
effectivehealthcare.ahrq.gov/products/mental-health-apps/report
-
effectivehealthcare.ahrq.gov/products/dietary-protein-intake/protocol
-
effectivehealthcare.ahrq.gov/products/global-health-evidence-evaluation-framework/white-paper